Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Study Identifies Biomarker Linked to… >
Study Identifies Biomarker Linked to Poor Outcomes in Pregnant Lupus Patients

Published: October 28, 2013.
By Hospital for Special Surgery
http://www.hss.edu

Researchers at Hospital for Special Surgery in New York City have identified a biomarker that may predict poor pregnancy outcomes in lupus patients.

The study, titled "Angiogenic Factor Dysregulation and Risk of Adverse Pregnancy Outcome In Lupus Pregnancies" will be presented at the American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting on October 27 in San Diego.

Investigators found that an imbalance of angiogenic factors, proteins required for the development of the placenta and the health of blood vessels, is associated with poor pregnancy outcomes. Increased levels of an anti-angiogenic protein called sFlt1 in pregnant lupus patients placed them at increased risk of placental insufficiency and preeclampsia, a potentially life-threatening complication. Scientists determined that higher levels of sFlt1 reduce the activity of other angiogenic proteins (placental growth factor, PIGF; vascular endothelial growth factor, VEGF) that are necessary for growth of the placenta and the mother's blood vessels.

"Pregnant women with lupus or antiphospholipid syndrome are at increased risk for adverse outcomes, particularly preeclampsia, yet identification of those destined for complications has been elusive," said Jane Salmon, MD, director of the Lupus and APS Center of Excellence at Hospital for Special Surgery and lead author of the study. "We prospectively studied patients to see if we could find a biomarker early in pregnancy that would predict a poor outcome."

The study is part of an ongoing, multi-center research initiative led by Dr. Salmon known as PROMISSE (Predictors of pRegnancy Outcome: bioMarkers In antiphospholipid antibody Syndrome and Systemic lupus Erythematosus) funded by the National Institutes of Health to identify factors that predict pregnancy complications in women with lupus and antiphospholipid syndrome.

Lupus is a chronic inflammatory disease in which the body's own immune system attacks tissues of the body and can cause complications during pregnancy. Preeclampsia, which is characterized by the onset of high blood pressure and impaired kidney function, is life-threatening to both mother and baby.

Scientists enrolled 384 pregnant women with lupus and 153 healthy pregnant controls.

Subjects were evaluated and blood was drawn monthly beginning 12 weeks into their pregnancy. Poor pregnancy outcomes were defined as preeclampsia, fetal death, neonatal death, preterm delivery before 36 weeks because of placental insufficiency, or intrauterine growth restriction (IUGR), which refers to a poor growth rate of the baby while in the womb. Levels of sFlt1 and other angiogenic proteins were measured and compared in women with lupus versus controls.

In the study, 20 percent of pregnant lupus patients developed preeclampsia or another poor outcome. Levels of sFlt1 protein, an anti-angiogenic factor, were significantly higher in patients destined for complications compared to lupus patients whose pregnancies were uncomplicated. In contrast, levels of PlGF, an angiogenic factor, were lower. Alteration in the balance of angiogenic factors was evident as early as 12 to 15 weeks into the pregnancy and persisted throughout pregnancy in women who experienced preeclampsia or another complication.

"Measurement of sFlt1 and PlGF provide a powerful tool to identify pregnant lupus patients at high risk for poor pregnancy outcomes sufficiently early to intervene," Dr. Salmon said. "Hopefully, this will facilitate trials of novel treatments to prevent these devastating complications."


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Pregnancy 
12/14/11 
★ 
Risk of Stillbirth Associated with Factors Known Early in Pregnancy
By University of Texas Medical Branch at Galveston
Stillbirth is associated with a range of health and socio-demographic factors identifiable before or at the start of pregnancy, including prior pregnancy outcomes, ethnicity and modifiable health factors, such …
Infant 
9/21/11 
Infant Mortality Linked to Subsequent Risk of Stillbirth Finds New US Study
By Wiley-Blackwell
Women whose first pregnancy ended in infant death are significantly more likely to have a subsequent stillbirth finds new research published today (21 September) in BJOG: An International Journal …
Weeks 
12/15/11 
Pregnant Women Advised to Stay Cool for Baby's Sake
By Queensland University of Technology
Queensland University of Technology (QUT) world-first research has found a link between increases in temperature and the incidence of stillbirth and shorter pregnancies. Associate Professor Adrian Barnett of …
Women 
7/4/12 
Study Sheds Light on Pregnancy Complications And Overturns Common Belief
By Hospital for Special Surgery
A study led by Hospital for Special Surgery researchers has demonstrated that women who have a specific type of antibody that interferes with blood vessel function are at risk …
Pce 
9/30/14 
Contaminated Water Linked to Pregnancy Complications, BU Study Finds
By Boston University Medical Center
Prenatal exposure to tetrachloroethylene (PCE) in drinking water may increase the risk of stillbirth and placental abruption, according to a new study led by a Boston University School of …
Positive 
3/3/11 
Solving the Puzzle of Henry VIII
By Southern Methodist University
DALLAS (SMU) – Blood group incompatibility between Henry VIII and his wives could have driven the Tudor king's reproductive woes, and a genetic condition related to his suspected blood …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition